市場調查報告書

智慧吸入器的全球市場 (2019∼2026年)

Global Smart Inhalers Market - 2019-2026

出版商 DataM Intelligence 商品編碼 950556
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
智慧吸入器的全球市場 (2019∼2026年) Global Smart Inhalers Market - 2019-2026
出版日期: 2020年07月18日內容資訊: 英文
簡介

由於空氣污染和吸煙者的增加,世界各國的哮喘和COPD(慢性阻塞性肺疾病)患者數量正在增加,這推動了對智慧型吸入器的市場需求。最近,還開發了與智慧型手機和應用程序兼容的產品並將其投放市場。儘管世界大多數市場都在北美和歐洲,但亞太地區的市場也在快速增長。

本報告提供全球智慧吸入器的市場相關分析,提供市場基本結構及最新形勢,整體市場趨勢預測 (今後8年份),各類型·各適應症·各流通管道及地區別詳細趨勢,主要的推動及阻礙市場要素,市場競爭結構,主要企業的簡介·事業策略等相關調查。

第1章 全球智慧吸入器市場:分析方法·範圍

第2章 全球智慧吸入器市場:定義和概要

第3章 全球智慧吸入器市場:摘要整理

第4章 全球智慧吸入器市場:市場動態

  • 對市場的影響要素
    • 促進因素
    • 阻礙因素
    • 影響力分析
  • 市場機會

第5章 全球智慧吸入器市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 法規分析
  • 價格分析

第6章 全球智慧吸入器市場:各類型

  • 簡介
    • 市場規模的分析與對前一年 (YoY) 成長率:各類型
    • 市場向心力指數:各類型
  • 乾粉吸入劑 (DPI)
    • 簡介
    • 市場規模·與前一年同期相比成長率 (2018∼2026年)
  • 鼻子吸入器
  • 定量吸入器 (MDI)
  • 其他

第7章 全球智慧吸入器市場:各流通管道

  • 簡介
  • 零售藥局
  • 呼吸系統照護中心
  • 醫院藥局
  • 線上藥局

第8章 全球智慧吸入器市場:各適應症

  • 簡介
  • 氣喘
  • 慢性阻塞性肺病(COPD)
  • 其他

第9章 全球智慧吸入器市場:各地區

  • 簡介
  • 北美
    • 簡介
    • 域內市場固有趨勢
    • 市場規模的分析與與前一年同期相比成長率:各類型
    • 市場規模的分析與與前一年同期相比成長率:各適應症
    • 市場規模的分析與與前一年同期相比成長率:各流通管道
    • 市場規模的分析與與前一年同期相比成長率:各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第10章 全球智慧吸入器市場:競爭環境

  • 競爭方案
  • 市場定位/佔有率分析
  • 企業合併·收購 (M&A)的分析

第11章 全球智慧吸入器市場:企業簡介

  • Merck
    • 企業概要
    • 產品的組合/概要
    • 近幾年趨勢
    • 財務分析:概要
  • Novartis
  • Vectura Group
  • MannKind
  • Respirices
  • Orion Pharm
  • Hovione
  • AstraZeneca
  • OPKO Health Inc
  • Boehringer-Ingelheim
  • 3M
  • Teva
  • Sunovion Pharmaceuticals
  • Aristopharma
  • GlaxoSmithKline
  • Cohero Health LLC
  • List is not exhaustive

第12章 重要考察

第13章 關於DataM Intelligence

目錄

Market Overview

Smart inhalers are connected to the multiple devices like mobile, laptops, personal computers etc. to monitor the patient's information related to respiratory diseases. Smart inhalers can be connected through mobile Indication which helps patients and healthcare providers to monitor important information like medication schedules and dosage reminders. Inhalers uses bluetooth technology to detect, remind patients about the inhalers use, and medication timing to take care of patients. Smart inhalers have the potential to improve patients' health to provide crucial for asthma and COPD information to keep their condition under control. The global Smart inhalers market valued USD XX million in 2018 and it is expected to grow at a CAGR of XX% to reach USD XX million by 2026.

Market Dynamics:

The market is driven by the rising demand for smart inhalers owing to increasing prevalence of Asthma, COPD, due to surge in air pollution and smoking habits among the people. According to the World Health Organization in 2016, the estimated Asthma patients were over 339 million people globally which most common disease among children and geriatric population. This is growing non-communicable disease owing to surge in smoking habits and rising global air pollution. Smart inhalers can be connected via wireless technology through mobile app & web platform providing crucial for asthma collects data for doctors about each drug usage and information.

There is a rise in the launching and FDA clearance of new innovative technology implemented with patient monitoring and tracking bluetooth enabled and app based smart inhalers for Asthma and other respiratory diseases. On 23rd Jan 2020, U.S. Food and Drugs Administration (FDA) has been cleared smart inhaler cap from Cognita Labs Known as CapMedic. The device has the ability to track signals of patients which has feedback mechanism and provides guidance to use inhalers correctly.

Segment Analysis

The global Smart inhalers market is segmented based on Type, distribution channel, Indication, and region.

In terms of Type the global smart inhalers marker is bifurcated into dry powder inhalers, nasal inhalers, metered dose inhalers, and others. Among this metered dose inhalers segment has highest share in 2019 owing to increasing new technology based launching of smart inhalers by the prominent players like Merck, Novartis, Vectura Group, MannKind, Respirices and Lupin. For instance 22nd Nov 2019, Lupin Company had been launched ADHERO as smart device for metered-dose inhalers. This inhaler has facility to connect with smartphone Indication via bluetooth. It is reusable smart device which tracks and send reminders to the patient's daily medication usage and consumption patterns via smartphone through "MyAdhero" app.

Similarly, dry powder inhalers, and nasal inhalers are also growing at faster pace owing to surge in the prevalence of respiratory diseases like Asthma, COPD, and many others across the globe with surge in the population. Dry powder inhalers is growing at faster pace due to rising awareness of its advantages like it avoids drug irritation and easy to use.

Depending upon indication, the global smart inhalers market is divided into Asthma

and chronic obstructive pulmonary disease (COPD). Among this Asthma segment has the largest share owing to increasing prevalence of Asthma disease around the globe due to surge in smoking habits of the people.

Similarly chronic obstructive pulmonary disease (COPD) segment is also growing at faster pace with surge in the global COPD disease burden. According to the World Health Organization in 2016, Global Burden of COPD Disease was reported around more than 251 million cases with estimated that 3.17 million deaths caused in 2015. This is primarily due to increasing the air pollution around the globe which propels this segmental growth during the forecast period.

Depending on the distribution channel, the global smart inhalers are segmented into retail pharmacies, respiratory care centers, hospital pharmacies and online pharmacies. Among this, retail pharmacies segment has the highest market share in 2019. This growth is anticipated due rise in the retail shops of pharmacies with increasing the awareness about the non-communication diseases like Asthma, COPD etc. among the people.

Similarly, online pharmacies segment has the highest market share owing to increase in the healthcare online consulting trends with surge in the online sales through portals like Flipkart, Amazon, etc.

Furthermore respiratory care centers, and hospital pharmacies are also growing at faster pace owing to increasing the number of hospitals and respiratory centers around the globe with surge in the prevalence of respiratory diseases owing to surge in the global air pollution due to smoke. According to the World Health Organization, there were at least around 2 billion people were exposed to the toxic smoke of biomass fuel in 2016.

Geographical Presentation

By region, the global Smart inhalers market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global smart inhalers market and expected to grow at the highest CAGR during the forecasted period due to presence of advanced technology adoption and surge in prevalence of respiratory diseases followed by Europe region. According to American Lung Association in 2016, there were around 3.5 million peoples and estimated around 6.1 million children under 18 years were affected due to Ashtma in North America followed by Europe. This propels the smart inhalers demand in this region with increasing the number of leading players and presence of advanced technology in this region.

The Asia-Pacific region is expected to have positive market growth due to the growing prevalence of Asthma due to surge in smoking habits and increasing air pollution. Forum of International Respiratory Societies in 2016, China has reported more than 300 million smokers with annual consumption of 2 trillion cigarettes, highest tobacco consuming nation with record of a single person dies every 30 seconds from tobacco use. Furthermore, increasing adoption of advanced technology to prevent such respiratory disorders with the help of smart inhalers with surge in population shall boost the demand for the market over the forecasted period.

Competitive Analysis

The global smart inhalers market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition Merck, Novartis, Vectura Group, MannKind, Respirices, Orion Pharm, Hovione, AstraZeneca, OPKO Health Inc, Boehringer-Ingelheim, 3M, Teva, Sunovion Pharmaceuticals, Aristopharma, GlaxoSmithKline and Cohero Health LLC are the leading market players with significant market share.

Major players are receiving launching new technology sensors and app based advanced smart inhalers for curing respiratory diseases in healthcare industry. For instance on 22nd Jan 2020, Teva Company had launched the world's first smart inhaler which was approved by the FDA. Teva's smart inhaler named ProAir Digihaler which was being launched in the United States market through a sNDA Indication. The ProAir Digihaler has a sensor used in real-time tracking, monitoring the patients and collecting the syncs data through a mobile app.

Companies are entering into the collaborations, acquisitions, mergers, and licensing for increasing their market penetration. For instance, on 28th January, 2020 Aptar Pharma, a leading drug delivery services and active packaging solutions Company has been partnered with Lupin Limited to launch India's first smart connected device for metered-dose inhalers (MDI) called ADHERO.

Why Purchase the Report?

  • Visualize the composition of the global Smart inhalers market products in terms of Type, and Indication highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the global Smart inhalers market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global Smart inhalers market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • *The global Smart inhalers market report will provide access to approximately 53 market data tables, 44 figures, and 178 pages

Target Audience

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

Table of Contents

1. Global Smart inhalers Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Smart inhalers Market - Market Definition and Overview

3. Global Smart inhalers Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Distribution Channel
  • 3.3. Market Snippet by Indication
  • 3.4. Market Snippet by Region

4. Global Smart inhalers Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Impact Analysis
  • 4.2. Opportunity

5. Global Smart inhalers Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis

6. Global Smart inhalers Market - By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Dry Powder Inhalers for the Smart Inhalers industry
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    • 6.2.3. Nasal Inhalers
    • 6.2.4. Metered Dose Inhalers
    • 6.2.5. Others

7. Global Smart inhalers Market - By Distribution Channel

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 7.1.2. Market Attractiveness Index, By Distribution Channel
  • 7.2. Retail Pharmacies
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, USD Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 7.3. Respiratory Care Centers
  • 7.4. Hospital Pharmacies
  • 7.5. Online Pharmacies

8. Global Smart inhalers Market - By Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 8.1.2. Market Attractiveness Index, By Indication
  • 8.2. Asthma
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, USD Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 8.3. Chronic obstructive pulmonary disease (COPD)
  • 8.4. Others

9. Global Smart inhalers Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication

10. Global Smart inhalers Market Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Global Smart inhalers Market Company Profiles

  • 11.1. Merck
    • 11.1.1. Company Overview
    • 11.1.2. Form Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Novartis
  • 11.3. Vectura Group
  • 11.4. MannKind
  • 11.5. Respirices
  • 11.6. Orion Pharm
  • 11.7. Hovione
  • 11.8. AstraZeneca
  • 11.9. OPKO Health Inc
  • 11.10. Boehringer-Ingelheim
  • 11.11. 3M
  • 11.12. Teva
  • 11.13. Sunovion Pharmaceuticals
  • 11.14. Aristopharma
  • 11.15. GlaxoSmithKline
  • 11.16. Cohero Health LLC
  • List is not exhaustive

12. Global Smart inhalers Market - Premium Insights

13. Global Smart inhalers Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us